Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinoli n3-yl-2,3-dihydro-imidazo[4,5-c]quinolin1-yl)-phenyl] -propionitrile

Details for Australian Patent Application No. 2007323820 (hide)

Owner Novartis AG

Inventors Stowasser, Frank; Banziger, Markus; Garad, Sudhakar Devidasrao

Agent Davies Collison Cave

Pub. Number AU-B-2007323820

PCT Pub. Number WO2008/064093

Priority 60/866,483 20.11.06 US

Filing date 16 November 2007

Wipo publication date 29 May 2008

Acceptance publication date 23 February 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/064093 Priority application(s): WO2008/064093

23 February 2012 Application Accepted

  Published as AU-B-2007323820

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007323824-Folding table and seating system

2007323809-Methods for RNA desilylation